Aldeyra Therapeutics (ALDX) Tops Q2 EPS by 3c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.41), $0.03 better than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
• Nvidia and Broadcom earnings: TD Cowen says earnings won’t settle big questions